Brigade Enterprises Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 9, 2025, 11:15 am

Quick Insight

Brigade Enterprises Ltd. is currently trading at ₹1,058, reflecting a market capitalization of ₹25,851 crore and a price-to-earnings (P/E) ratio of 38.0, indicating a premium valuation in the realty sector. With a return on equity (ROE) of 14.6% and a return on capital employed (ROCE) of 13.4%, the company demonstrates strong profitability metrics. However, its high price-to-book value (P/BV) ratio of 6.16x suggests that investors may be paying a hefty premium for future growth. The company’s interest coverage ratio (ICR) of 2.77x indicates manageable debt levels against its ₹5,464 crore borrowings, although a cash conversion cycle (CCC) of 2,290 days raises concerns about efficiency. With promoters holding 41.37% and institutional investors (FIIs and DIIs) comprising 43.14%, Brigade appears well-supported by its shareholders. Overall, while Brigade Enterprises shows robust financial health, potential investors should weigh the high valuation against operational efficiency before making decisions.

Competitors of Brigade Enterprises Ltd

All Competitor Stocks of Brigade Enterprises Ltd

Quarterly Result

Last Updated: May 31, 2025, 9:36 am

Below is a detailed analysis of the quarterly data for Brigade Enterprises Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 1,460.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,464.00 Cr. (Dec 2024) to 1,460.00 Cr., marking a decrease of 4.00 Cr..
• For Expenses, as of Mar 2025, the value is 1,044.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,050.00 Cr. (Dec 2024) to 1,044.00 Cr., marking a decrease of 6.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 416.00 Cr.. The value appears strong and on an upward trend. It has increased from 414.00 Cr. (Dec 2024) to 416.00 Cr., marking an increase of 2.00 Cr..
• For OPM %, as of Mar 2025, the value is 28.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 28.00%.
• For Other Income, as of Mar 2025, the value is 72.00 Cr.. The value appears strong and on an upward trend. It has increased from 66.00 Cr. (Dec 2024) to 72.00 Cr., marking an increase of 6.00 Cr..
• For Interest, as of Mar 2025, the value is 107.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 114.00 Cr. (Dec 2024) to 107.00 Cr., marking a decrease of 7.00 Cr..
• For Depreciation, as of Mar 2025, the value is 76.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 76.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 306.00 Cr.. The value appears strong and on an upward trend. It has increased from 289.00 Cr. (Dec 2024) to 306.00 Cr., marking an increase of 17.00 Cr..
• For Tax %, as of Mar 2025, the value is 18.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 18.00%.
• For Net Profit, as of Mar 2025, the value is 249.00 Cr.. The value appears strong and on an upward trend. It has increased from 236.00 Cr. (Dec 2024) to 249.00 Cr., marking an increase of 13.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 10.10. The value appears strong and on an upward trend. It has increased from 9.67 (Dec 2024) to 10.10, marking an increase of 0.43.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 7:03 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 12:20 pm

Below is a detailed analysis of the balance sheet data for Brigade Enterprises Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 244.00 Cr.. The value appears strong and on an upward trend. It has increased from 231.00 Cr. (Mar 2024) to 244.00 Cr., marking an increase of 13.00 Cr..
• For Reserves, as of Mar 2025, the value is 5,394.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,418.00 Cr. (Mar 2024) to 5,394.00 Cr., marking an increase of 1,976.00 Cr..
• For Borrowings, as of Mar 2025, the value is 5,464.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 5,470.00 Cr. (Mar 2024) to 5,464.00 Cr., marking a decrease of 6.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 10,988.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8,740.00 Cr. (Mar 2024) to 10,988.00 Cr., marking an increase of 2,248.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 22,090.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17,860.00 Cr. (Mar 2024) to 22,090.00 Cr., marking an increase of 4,230.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 6,902.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,593.00 Cr. (Mar 2024) to 6,902.00 Cr., marking an increase of 2,309.00 Cr..
• For CWIP, as of Mar 2025, the value is 138.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,232.00 Cr. (Mar 2024) to 138.00 Cr., marking a decrease of 1,094.00 Cr..
• For Investments, as of Mar 2025, the value is 41.00 Cr.. The value appears to be declining and may need further review. It has decreased from 50.00 Cr. (Mar 2024) to 41.00 Cr., marking a decrease of 9.00 Cr..
• For Other Assets, as of Mar 2025, the value is 15,010.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,985.00 Cr. (Mar 2024) to 15,010.00 Cr., marking an increase of 3,025.00 Cr..
• For Total Assets, as of Mar 2025, the value is 22,090.00 Cr.. The value appears strong and on an upward trend. It has increased from 17,860.00 Cr. (Mar 2024) to 22,090.00 Cr., marking an increase of 4,230.00 Cr..

However, the Borrowings (5,464.00 Cr.) are higher than the Reserves (5,394.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Brigade Enterprises Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 19.56. This value is within the healthy range. It has increased from 12.64 (Mar 23) to 19.56, marking an increase of 6.92.
• For Diluted EPS (Rs.), as of Mar 24, the value is 19.51. This value is within the healthy range. It has increased from 12.64 (Mar 23) to 19.51, marking an increase of 6.87.
• For Cash EPS (Rs.), as of Mar 24, the value is 30.43. This value is within the healthy range. It has increased from 23.09 (Mar 23) to 30.43, marking an increase of 7.34.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 147.83. It has increased from 133.10 (Mar 23) to 147.83, marking an increase of 14.73.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 148.19. It has increased from 133.46 (Mar 23) to 148.19, marking an increase of 14.73.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 211.89. It has increased from 149.29 (Mar 23) to 211.89, marking an increase of 62.60.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 58.93. This value is within the healthy range. It has increased from 42.37 (Mar 23) to 58.93, marking an increase of 16.56.
• For PBIT / Share (Rs.), as of Mar 24, the value is 45.85. This value is within the healthy range. It has increased from 28.74 (Mar 23) to 45.85, marking an increase of 17.11.
• For PBT / Share (Rs.), as of Mar 24, the value is 24.61. This value is within the healthy range. It has increased from 11.87 (Mar 23) to 24.61, marking an increase of 12.74.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 17.35. This value is within the healthy range. It has increased from 9.45 (Mar 23) to 17.35, marking an increase of 7.90.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 19.54. This value is within the healthy range. It has increased from 12.63 (Mar 23) to 19.54, marking an increase of 6.91.
• For PBDIT Margin (%), as of Mar 24, the value is 27.81. This value is within the healthy range. It has decreased from 28.38 (Mar 23) to 27.81, marking a decrease of 0.57.
• For PBIT Margin (%), as of Mar 24, the value is 21.64. This value exceeds the healthy maximum of 20. It has increased from 19.24 (Mar 23) to 21.64, marking an increase of 2.40.
• For PBT Margin (%), as of Mar 24, the value is 11.61. This value is within the healthy range. It has increased from 7.95 (Mar 23) to 11.61, marking an increase of 3.66.
• For Net Profit Margin (%), as of Mar 24, the value is 8.19. This value is within the healthy range. It has increased from 6.33 (Mar 23) to 8.19, marking an increase of 1.86.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 9.22. This value is within the healthy range. It has increased from 8.45 (Mar 23) to 9.22, marking an increase of 0.77.
• For Return on Networth / Equity (%), as of Mar 24, the value is 12.87. This value is below the healthy minimum of 15. It has increased from 9.18 (Mar 23) to 12.87, marking an increase of 3.69.
• For Return on Capital Employeed (%), as of Mar 24, the value is 11.97. This value is within the healthy range. It has increased from 8.69 (Mar 23) to 11.97, marking an increase of 3.28.
• For Return On Assets (%), as of Mar 24, the value is 2.52. This value is below the healthy minimum of 5. It has increased from 1.77 (Mar 23) to 2.52, marking an increase of 0.75.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 1.39. This value exceeds the healthy maximum of 1. It has increased from 1.32 (Mar 23) to 1.39, marking an increase of 0.07.
• For Total Debt / Equity (X), as of Mar 24, the value is 1.52. This value exceeds the healthy maximum of 1. It has increased from 1.43 (Mar 23) to 1.52, marking an increase of 0.09.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.28. It has increased from 0.18 (Mar 23) to 0.28, marking an increase of 0.10.
• For Current Ratio (X), as of Mar 24, the value is 1.16. This value is below the healthy minimum of 1.5. It has increased from 1.11 (Mar 23) to 1.16, marking an increase of 0.05.
• For Quick Ratio (X), as of Mar 24, the value is 0.30. This value is below the healthy minimum of 1. It has increased from 0.27 (Mar 23) to 0.30, marking an increase of 0.03.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 0.02. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 23) to 0.02, marking an increase of 0.02.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 10.22. This value is below the healthy minimum of 20. It has decreased from 11.85 (Mar 23) to 10.22, marking a decrease of 1.63.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 6.12. This value is below the healthy minimum of 20. It has increased from 5.70 (Mar 23) to 6.12, marking an increase of 0.42.
• For Earning Retention Ratio (%), as of Mar 24, the value is 89.78. This value exceeds the healthy maximum of 70. It has increased from 88.15 (Mar 23) to 89.78, marking an increase of 1.63.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 93.88. This value exceeds the healthy maximum of 70. It has decreased from 94.30 (Mar 23) to 93.88, marking a decrease of 0.42.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 2.77. This value is below the healthy minimum of 3. It has increased from 2.25 (Mar 23) to 2.77, marking an increase of 0.52.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 1.82. This value is below the healthy minimum of 3. It has increased from 1.40 (Mar 23) to 1.82, marking an increase of 0.42.
• For Enterprise Value (Cr.), as of Mar 24, the value is 25,130.78. It has increased from 13,910.61 (Mar 23) to 25,130.78, marking an increase of 11,220.17.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 5.13. This value exceeds the healthy maximum of 3. It has increased from 4.04 (Mar 23) to 5.13, marking an increase of 1.09.
• For EV / EBITDA (X), as of Mar 24, the value is 18.45. This value exceeds the healthy maximum of 15. It has increased from 14.23 (Mar 23) to 18.45, marking an increase of 4.22.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 4.42. This value exceeds the healthy maximum of 3. It has increased from 3.18 (Mar 23) to 4.42, marking an increase of 1.24.
• For Retention Ratios (%), as of Mar 24, the value is 89.77. This value exceeds the healthy maximum of 70. It has increased from 88.14 (Mar 23) to 89.77, marking an increase of 1.63.
• For Price / BV (X), as of Mar 24, the value is 6.16. This value exceeds the healthy maximum of 3. It has increased from 3.45 (Mar 23) to 6.16, marking an increase of 2.71.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 4.42. This value exceeds the healthy maximum of 3. It has increased from 3.18 (Mar 23) to 4.42, marking an increase of 1.24.
• For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness